ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Hmg vs hcg
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Nelson Vergel" data-source="post: 47713" data-attributes="member: 3"><p>HMG is very expensive. No one has done a study comparing TRT+HCG versus HMG vs HCG + HMG. Several studies on HCG + HMG show positive results on sperm improvement.</p><p></p><p></p><p><strong>Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism</strong></p><p></p><p>Clinical Endocrinology</p><p>Volume 38, Issue 2</p><p>February 1993 </p><p>Pages 203–208</p><p></p><p></p><p><strong>Summary</strong></p><p></p><p>OBJECTIVE We determined whether or not self-administered subcutaneous human menopausal gonadotrophin (hMG) therapy is safe and effective in the stimulation of testicular growth and initiation of spermatogenesis In men with hypogonadotrophic hypogonadism where human chorionic gonadotrophin alone had failed.</p><p></p><p>DESIGN Human menopausal gonadotrophin was self-administered subcutaneously in two dosage regimens to patients requiring (a) fertility (Group I), 37.5 IU twice daily (total weekly dose 525 IU) (<em>n</em>= 7) and (b) increased testicular size (Group II) 37.5 IU once daily (total weekly dose 265.5 IU) (<em>n</em>=2). Patients were assessed on a monthly basis.</p><p></p><p>PATIENTS Nine patients with hypogonadotrophic hypogonadism were studied. Six patients had Idiopathic isolated hypogonadotrophic hypogonadism, one Kallman's syndrome, one idiopathic isolated hypogonadotrophic hypogonadism secondary to trauma and one with panhypopituitarism secondary to radiotherapy for a hypothalamic pituitary tumour. Five of these patients had a history of unilateral or bilateral cryptorchidism.</p><p></p><p>MEASUREMENTS Semen analysis and serum testosterone. Testicular size was assessed by use of a Prader orchidometer.</p><p></p><p>RESULTS Six of seven patients (four with a history of cryptorchidism) requesting fertility attained sperm counts of < 10 million/ml. Three pregnancies have been achieved so far. One failure occurred in a patient with a previous history of cryptorchidism. In Group I patients (a) with an initial testicular volume of 4 ml or less (<em>n</em>= 4), mean size increased from 3.25·0.9 (SD) ml to 12.2·3.8 ml, (b) an initial testicular volume of <4 ml mean size (<em>n</em>= 3) increased from 9.2 ± 3.9 ml to 10.3 ± 4 ml. In Group II (<em>n</em>= 2) testis size increased from a mean of 3.0 ± 1.4 ml to 9.0 ± 1.4 ml over a 6-months treatment period.</p><p></p><p>CONCLUSION Self-administered subcutaneous human menopausal gonadotrophin is a safe and effective mode of therapy in increasing testicular size and inducing spermatogenesis in males with hypogonadotrophic hypogonadism.</p></blockquote><p></p>
[QUOTE="Nelson Vergel, post: 47713, member: 3"] HMG is very expensive. No one has done a study comparing TRT+HCG versus HMG vs HCG + HMG. Several studies on HCG + HMG show positive results on sperm improvement. [B]Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic hypogonadism[/B] Clinical Endocrinology Volume 38, Issue 2 February 1993 Pages 203–208 [B]Summary[/B] OBJECTIVE We determined whether or not self-administered subcutaneous human menopausal gonadotrophin (hMG) therapy is safe and effective in the stimulation of testicular growth and initiation of spermatogenesis In men with hypogonadotrophic hypogonadism where human chorionic gonadotrophin alone had failed. DESIGN Human menopausal gonadotrophin was self-administered subcutaneously in two dosage regimens to patients requiring (a) fertility (Group I), 37.5 IU twice daily (total weekly dose 525 IU) ([I]n[/I]= 7) and (b) increased testicular size (Group II) 37.5 IU once daily (total weekly dose 265.5 IU) ([I]n[/I]=2). Patients were assessed on a monthly basis. PATIENTS Nine patients with hypogonadotrophic hypogonadism were studied. Six patients had Idiopathic isolated hypogonadotrophic hypogonadism, one Kallman's syndrome, one idiopathic isolated hypogonadotrophic hypogonadism secondary to trauma and one with panhypopituitarism secondary to radiotherapy for a hypothalamic pituitary tumour. Five of these patients had a history of unilateral or bilateral cryptorchidism. MEASUREMENTS Semen analysis and serum testosterone. Testicular size was assessed by use of a Prader orchidometer. RESULTS Six of seven patients (four with a history of cryptorchidism) requesting fertility attained sperm counts of < 10 million/ml. Three pregnancies have been achieved so far. One failure occurred in a patient with a previous history of cryptorchidism. In Group I patients (a) with an initial testicular volume of 4 ml or less ([I]n[/I]= 4), mean size increased from 3.25·0.9 (SD) ml to 12.2·3.8 ml, (b) an initial testicular volume of <4 ml mean size ([I]n[/I]= 3) increased from 9.2 ± 3.9 ml to 10.3 ± 4 ml. In Group II ([I]n[/I]= 2) testis size increased from a mean of 3.0 ± 1.4 ml to 9.0 ± 1.4 ml over a 6-months treatment period. CONCLUSION Self-administered subcutaneous human menopausal gonadotrophin is a safe and effective mode of therapy in increasing testicular size and inducing spermatogenesis in males with hypogonadotrophic hypogonadism. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Side Effect Management
Hmg vs hcg
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top